A quantitative and qualitative method to control chemotherapeutic preparations by Fourier transform infrared–ultraviolet spectrophotometry.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Works matching IS 10781552 AND DT 2013 AND VI 19 AND IP 2
Results: 18
1
2
Evaluation of clinical pharmacists’ follow-up service in an oncology pain clinic.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
3
Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 99, doi. 10.1177/1078155212468367
- By:
- Publication type:
- Article
4
Severe neurological symptoms in a patient with advanced renal cell carcinoma treated with sunitinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 186, doi. 10.1177/1078155212457967
- By:
- Publication type:
- Article
5
A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 138, doi. 10.1177/1078155212457966
- By:
- Publication type:
- Article
6
Cetuximab infusion reactions: French pharmacovigilance database analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 130, doi. 10.1177/1078155212457965
- By:
- Publication type:
- Article
7
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 159, doi. 10.1177/1078155212457964
- By:
- Publication type:
- Article
8
A quantitative and qualitative method to control chemotherapeutic preparations by Fourier transform infrared–ultraviolet spectrophotometry.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 121, doi. 10.1177/1078155212457963
- By:
- Publication type:
- Article
9
Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 111, doi. 10.1177/1078155212457806
- By:
- Publication type:
- Article
10
Evaluation of clinical pharmacists’ follow-up service in an oncology pain clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 151, doi. 10.1177/1078155212457805
- By:
- Publication type:
- Article
11
Adherence to adjuvant endocrine therapy in women with breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 105, doi. 10.1177/1078155212455939
- By:
- Publication type:
- Article
12
Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 145, doi. 10.1177/1078155212455446
- By:
- Publication type:
- Article
13
Coadministration of 5% glucose solution relieves vascular pain in the patients administered gemcitabine immediately.
- Published in:
- 2013
- By:
- Publication type:
- Letter
14
Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 181, doi. 10.1177/1078155212448408
- By:
- Publication type:
- Article
15
Aseptic meningitis: A rare side effect of cetuximab therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 178, doi. 10.1177/1078155212447973
- By:
- Publication type:
- Article
16
Successful treatment of nilotinib-induced pleural effusion with prednisone.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 175, doi. 10.1177/1078155212447530
- By:
- Publication type:
- Article
17
Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
18
Hair repigmentation associated with the use of lenalidomide: Graying may not be an irreversible process!
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 2, p. 165, doi. 10.1177/1078155212442561
- By:
- Publication type:
- Article